Exparel and Education to Avoid Opioids After Carpal Tunnel Release
Recruiting
Phase 4
Interventional Study
Carpal Tunnel Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 64 (estimated)
- Sponsor
- Kettering Health Network · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* carpal tunnel syndrome diagnosed either by physical exam or EMG
* age \>18.
Exclusion Criteria:
* allergy to bupivacaine
* pre-operative opioid usage within the last six months
* patients allergic to Percocet or acetaminophen
* patients taking tricyclic antidepressants (inte…
Contacts